Edition:
United States

Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

0.65USD
21 Sep 2018
Change (% chg)

$0.07 (+12.80%)
Prev Close
$0.58
Open
$0.57
Day's High
$0.65
Day's Low
$0.55
Volume
75,263
Avg. Vol
43,169
52-wk High
$7.49
52-wk Low
$0.50

Chart for

About

Jaguar Health, Inc., formerly Jaguar Animal Health, Inc., is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuti... (more)
No analyst recommendations are available for .

Overall

Beta: -0.72
Market Cap(Mil.): $6.21
Shares Outstanding(Mil.): 9.53
Dividend: --
Yield (%): --

Financials

  JAGX.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -3.64 -- --
ROI: -203.09 1.50 12.72
ROE: -768.79 0.19 14.85

BRIEF-Jaguar Health Files For Resale Of Up To 29.4 Mln Shares Common Stock By The Selling Shareholders

* JAGUAR HEALTH INC FILES FOR RESALE OF UP TO 29.4 MILLION SHARES COMMON STOCK BY THE SELLING SHAREHOLDERS - SEC FILING Source : https://bit.ly/2qOl6Fa Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 20 2018

BRIEF-Jaguar Health Says Unit Signed Agreement With ADAP Crisis Task Force

* JAGUAR INC SAYS NAPO PHARMACEUTICALS HAS SIGNED AN AGREEMENT WITH ADAP CRISIS TASK FORCE

Apr 10 2018

BRIEF-Jaguar Health Inc Files For Non-Timely 10-K With U.S. SEC

* JAGUAR HEALTH INC FILES FOR NON-TIMELY 10-K WITH U.S. SEC Source text: (https://bit.ly/2GQ2TRx) Further company coverage:

Apr 02 2018

Earnings vs. Estimates